Search - tctmd.com

Displaying 741 - 757 of 757

Sort: Relevancy | Date

News Daily News

Superiority of Xience V Over Taxus in Women Sustained at 3 Years

February 03, 2011

News Daily News

Prasugrel Inhibits Platelet Function Better Than High-Dose Clopidogrel in Diabetics

January 26, 2011

News Daily News

Cell Therapy Trials Show Safety, Efficacy Signal in Critical Limb Ischemia

January 25, 2011

News Daily News

DES Linked with More Stent Thrombosis Than BMS 1 Year After Primary PCI

January 18, 2011

News Daily News

PES Show Delayed Healing in STEMI Patients, Clinical Significance Downplayed

January 12, 2011

News Daily News

Meta-Analysis Confirms Superiority of Simple Stenting for Bifurcations

January 10, 2011

News Daily News

Higher Long-term Mortality for Women Undergoing Primary PCI

January 10, 2011

News Daily News

Cell Therapy Shows Promise for Limb Ischemia Due to PAD, Buerger’s Disease

January 06, 2011

News Daily News

FAME Published: FFR Guidance Improves Outcomes in Multivessel Disease

January 14, 2009

Balancing Ischemic and Bleeding Risk with Antiplatelet Therapy: Personalizing Treatment to Optimize Outcomes

CME

Balancing Ischemic and Bleeding Risk with Antiplatelet Therapy: Personalizing Treatment to Optimize Outcomes

PLX Pharma - Aspirin for the Interventionalist: More Than Meets the Eye

CME

Aspirin for the Interventionalist: More Than Meets the Eye

TAVR: The Heart Team Approach

CME

TAVR: The Heart Team Approach

Changing Course with Anticoagulation in Secondary Prevention of CAD

CME

Changing Course with Anticoagulation in Secondary Prevention of CAD

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

CME

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

CME

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.